Skip to Main Content

Paper Details

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus.
Annals of the Rheumatic Diseases
15
2022
C-C motif chemokine ligand (CCL) 19, C-X-C motif chemokine ligand (CXCL) 10, CCL19, CD137, CXCL10, IFN, IL-12, IL-6, Interferon, Janus kinase (JAK) 1/2, PD-L1, Patients, SLE, Systemic Lupus Erythematosus, TNF, TNF receptor superfamily member (TNFRSF)9, TNF-?, TNFRSF9, anti-double stranded DNA, baricitinib, baricitinib 4, dsDNA, mRNA panel, patients, systemic lupus erythematosus, tumour necrosis factor alpha, type I IFN
Author NameAffiliation
Michelle PetriJohns Hopkins University
  • 1 - 1

Datasets

Release 1.2